[Efficacy of estrogens and progestational hormones in persistent hemorrhagic recurrences in digestive angiodysplasia after discontinuation of hormone therapy].
Li
V
V
D000368:Aged; D000369:Aged, 80 and over; D001165:Arteriovenous Malformations / Q000150:complications*; D004066:Digestive System Diseases / Q000150:complications*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009640:Norethindrone / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D013997:Time Factors
D004997:Ethinyl Estradiol; D009640:Norethindrone
L'efficacité des oestroprogestatifs sur les récidives hémorragiques des angiodysplasies digestives persiste après l'arrêt de l'hormonothérapie.